Navigation Links
FDA Panel Votes Against Approval of 'Female Viagra'
Date:6/18/2010

Little benefit seen in terms of increased libido, studies found

FRIDAY, June 18 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Friday unanimously agreed that a pill dubbed by some as a "female Viagra" did not show strong enough benefits to warrant approval.

Called flibanserin, the drug was aimed at premenopausal women with a diminished sex drive. It is related to the antidepressant family and affects serotonin and other chemicals in the brain. Drug maker Boehringer Ingelheim has been seeking FDA approval of the drug.

According to the Associated Press, the FDA advisers voted 11-0 that benefits linked to the pill did not outweigh side effects such as fainting spells, fatigue and depression.

While the agency isn't compelled to follow the recommendations of its advisory panels, it typically does so.

Earlier this week, the FDA released a review of two studies that found the drug didn't have much impact on a woman's libido but did seem to slightly boost sexual satisfaction, according to published reports.

The drug, with the proposed brand name Girosa, is designed to be taken in 100-milligram pills once a day at bedtime, according to the FDA.

Since the extraordinary success of Viagra for men, which hit the market a decade ago, pharmaceutical companies have repeatedly tried to find a comparable drug treatment for women. But none of those treatments has resulted in a significant benefit.

More information

To learn more about women's sexual health, visit the International Society for the Study of Women's Sexual Health.



-- HealthDay staff



SOURCES: U.S. Food and Drug Administration Web site


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. FDA Panel Weighs OK of Female Viagra
2. FDA Panel Backs New Morning After Pill
3. FDA Panel to Vote on New Morning After Pill
4. U.S. Panel Upholds Ban on Gay Men as Blood Donors
5. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
6. DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It
7. ANY LAB TEST NOW Launches New Infectious Disease Panels - Affordable Panels Test for H1N1, Staph, E. coli and Other Infectious Diseases
8. PSA-TEC to Present State of the Industry Panel Discussion
9. Panel recommends standardizing prescription container labeling
10. HIA-LI 22nd Annual Business Trade Show & Conference to Feature Healthcare Pavilion and Expert Panel Discussing Healthcare Economics and Politics
11. Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: